Article Sidebar

PDF (Tiếng Việt)
Published: 2024-02-27
Abstract Views: 144
Views PDF (Tiếng Việt): 136
DOI: https://doi.org/10.52852/tcncyh.v174i1.2204
Issue
Vol. 174 No. 1 (2024)
Section
Các bài báo
How to Cite
Ngọc, N. D. ., Khánh, T. V. ., Thúy, N. T. ., Phương, L. T. ., Thịnh, T. H. ., Thái, P. V. ., Tâm, L. Đức ., & Hùng, K. Đình . (2024). 4. Studying miRNA-29b expression level in glioma patients. Journal of Medical Research, 174(1), 27-33. https://doi.org/10.52852/tcncyh.v174i1.2204

4. Studying miRNA-29b expression level in glioma patients

Nguyen Duy Ngoc, Tran Van Khanh, Nguyen Thu Thuy, Le Thi Phuong, Tran Huy Thinh, Pham Van Thai, Le Duc Tam, Kieu Dinh Hung

Main Article Content

Abstract

Gliomas develop from undifferentiated or poorly differentiated glial cells in the brain. Many studies have shown that the pathogenesis of glioma relates to the variable expression levels of miRNAs. miRNA-29b promotes apoptosis and inhibits proliferation in glioma cells. This study aimed to determine miRNA-29b expression level in peripheral blood of glioma patients. The expression of miRNA-29b was detected in plasma from 62 post-operative gliomas and 62 healthy controls using realtime-PCR technique. The results showed that the expression level of miRNA-29b was not different between gliomas and controls. We found no corelation between miRNA-29b and characteristics of glioma group.

Article Details

Keywords

Gliomas, miRNA-29b, realtime-PCR

References

1. Ghosh M, Shubham S, Mandal K, et al. Survival and prognostic factors for glioblastoma multiforme: Retrospective single-institutional study. Indian J Cancer. 2017;54(1):362-367.
2. Nishikawa R, Ji XD, Harmon RC, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A. 1994;91(16):7727-7731.
3. Purow BW, Schiff D. Glioblastoma Genetics: In Rapid Flux. Discov Med. 2010;9(45):125-131.
4. Cortez MA, Nicoloso MS, Shimizu M, et al. miR-29b and miR-125a Regulate Podoplanin and Suppress Invasion in Glioblastoma. Genes Chromosomes Cancer. 2010;49(11):981-990.
5. Botta C, Cucè M, Pitari MR, et al. MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells. Leukemia. 2018;32(4):1003-1015. doi:10.1038/leu.2017.336
6. Pan Y, Zhang Y, Liu W, et al. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death Dis. 2019;10(2):1-14. doi:10.1038/s41419-018-1219-0
7. Wang T, Hou J, Jian S, et al. miR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth. J Cancer. 2018;9(20):3776-3786. doi:10.7150/jca.26263
8. Brower J, Clark PA, Lyon W, et al. MicroRNAs in Cancer: Glioblastoma and Glioblastoma Cancer Stem Cells. Neurochem Int. 2014;77:68-77.
9. Sun G, Lu J, Zhang C, et al. MiR-29b inhibits the growth of glioma via MYCN dependent way. Oncotarget. 2017;8(28):45224-45233. doi:10.18632/oncotarget.16780
10. Zhong F, Huang T, Leng J. Serum miR-29b as a novel biomarker for glioblastoma diagnosis and prognosis. Int J Clin Exp Pathol. 2019;12(11):4106-4112.
11. Shin J, Shim HG, Hwang T, et al. Restoration of miR-29b exerts anti-cancer effects on glioblastoma. Cancer Cell Int. 2017;17:104. doi:10.1186/s12935-017-0476-9
12. Jiang H, Zhang G, Wu JH, et al. Diverse roles of miR-29 in cancer (Review). Oncology Reports. 2014;31(4):1509-1516. doi:10.3892/or.2014.3036